Vivos Therapeutics's total assets for Q3 2025 were $25.64M, a decrease of -1.49% from the previous quarter. VVOS total liabilities were $23.11M for the fiscal quarter, a 7.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.